Kevin P. Bliden

Director of Clinical Trials
Sinai Hospital

Presentation(s):

• PB0060 - Hypercoagulability in COVID-19: Is there an Antiphospholipid Syndrome?

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB0598 - Demonstration of Prothrombotic Status in patients with COVID-19 using Thromboelastography and a Novel T-TAS assay

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PO0018 - Reference Range Determination for the Novel T-TAS 01 AR Assay

  Wednesday, July 13, 2022
  1:00 PM – 2:00 PM